Valneva Covid Shot Gets Fresh Blow With Veto From Home Regulator
A lab technician at the Valneva SA laboratories in Vienna.
Photographer: Akos Stiller/BloombergThis article is for subscribers only.
Valneva SE, the French company that raced to develop a Covid shot only to find that others beat it to the punch and potential buyers were no longer interested, received another blow on Thursday: even the local regulator won’t clear its shot.
France’s Haute Autorite de Sante approved another latecomer from Sanofi and GSK Plc but said it didn’t know how well the Valneva vaccine worked on the latest variants or how it stacked up against other products.